BPGbio is a clinical-stage biopharma reimagining how patient biology can be modeled using unbiased AI algorithms, to accelerate and de-risk the process of drug discovery for humanity. Our Interrogative Biology® platform has produced and guided the development of more than a dozen therapeutics and diagnostics candidates in the areas of oncology, neurology, and rare diseases, including several in advanced clinical stages. As BPGbio continues to expand our biobank and the network insights that are derived from it, we anticipate more promising discoveries made with improved time and cost efficiency.